17 patents
Utility
Methods and compositions for self-regulated release of active pharmaceutical ingredient
2 Jan 24
An abuse deterrent pharmaceutical composition including a pharmaceutically active ingredient; an acid soluble ingredient; and a buffering ingredient; wherein the acid soluble ingredient and the buffering ingredient retard release of the active pharmaceutical ingredient when the composition is ingested in excess of an intended dosage.
Albert W. Brzeczko, R. Gary Hollenbeck
Filed: 2 Jul 21
Utility
Methods and Compositions for Interfering with Extraction or Conversion of a Drug Susceptible to Abuse
19 Oct 23
Effective methods and compositions to deter abuse of pharmaceutical products (e.g., orally administered pharmaceutical products) including but not limited to immediate release, sustained or extended release and delayed release formulations for drugs subject to abuse.
Ronald L. Leech, JR.
Filed: 23 Jun 23
Utility
Methods and compositions for interfering with extraction or conversion of a drug susceptible to abuse
15 Aug 23
Effective methods and compositions to deter abuse of pharmaceutical products (e.g., orally administered pharmaceutical products) including but not limited to immediate release, sustained or extended release and delayed release formulations for drugs subject to abuse.
Ronald L. Leech, Jr.
Filed: 8 Nov 21
Utility
Methods and Compositions for Self-regulated Release of Active Pharmaceutical Ingredients
25 May 23
An abuse deterrent pharmaceutical composition including a drug susceptible to abuse, a first acid soluble ingredient, a first buffering ingredient, and a delayed release buffering component.
Albert W. Brzeczko, Robert Barnett Jones
Filed: 13 Dec 22
Utility
Methods and compositions for self-regulated release of active pharmaceutical ingredients
17 Jan 23
An abuse deterrent pharmaceutical composition including a drug susceptible to abuse, a first acid soluble ingredient, a first buffering ingredient, and a delayed release buffering component.
Albert W. Brzeczko, Robert Barnett Jones
Filed: 30 Mar 18
Utility
Methods and Compositions for Interfering with Extraction or Conversion of a Drug Susceptible to Abuse
3 Mar 22
Effective methods and compositions to deter abuse of pharmaceutical products (e.g., orally administered pharmaceutical products) including but not limited to immediate release, sustained or extended release and delayed release formulations for drugs subject to abuse.
Ronald L. Leech
Filed: 8 Nov 21
Utility
Methods and compositions for interfering with extraction or conversion of a drug susceptible to abuse
14 Dec 21
Effective methods and compositions to deter abuse of pharmaceutical products (e.g., orally administered pharmaceutical products) including but not limited to immediate release, sustained or extended release and delayed release formulations for drugs subject to abuse.
Ronald L. Leech, Jr.
Filed: 27 Feb 20
Utility
Methods and Compositions for Self-regulated Release of Active Pharmaceutical Ingredient
28 Oct 21
An abuse deterrent pharmaceutical composition including a pharmaceutically active ingredient; an acid soluble ingredient; and a buffering ingredient; wherein the acid soluble ingredient and the buffering ingredient retard release of the active pharmaceutical ingredient when the composition is ingested in excess of an intended dosage.
Albert W. BRZECZKO, R. Gary HOLLENBECK
Filed: 2 Jul 21
Utility
Methods and compositions for self-regulated release of active pharmaceutical ingredient
31 Aug 21
An abuse deterrent pharmaceutical composition including an acid soluble salt of a pharmaceutically active ingredient and a buffering ingredient; wherein the acid soluble salt of the pharmaceutically active ingredient and the buffering ingredient retard release of the pharmaceutically active ingredient when the composition is ingested in excess of an intended dosage.
Robert Barnett Jones
Filed: 31 Aug 16
Utility
Methods and compositions for self-regulated release of active pharmaceutical ingredient
10 Aug 21
An abuse deterrent pharmaceutical composition including a pharmaceutically active ingredient; an acid soluble ingredient; and a buffering ingredient; wherein the acid soluble ingredient and the buffering ingredient retard release of the active pharmaceutical ingredient when the composition is ingested in excess of an intended dosage.
Albert W. Brzeczko, R. Gary Hollenbeck
Filed: 11 Jun 20
Utility
Methods and Compositions for Self-regulated Release of Active Pharmaceutical Ingredients
22 Apr 21
An abuse deterrent pharmaceutical composition including a drug susceptible to abuse, a first acid soluble ingredient, a first buffering ingredient, and a delayed release buffering component.
Albert W. BRZECZKO, Robert Barnett JONES
Filed: 30 Mar 18
Utility
Abuse Deterrent Compositions and Methods of Making Same
18 Mar 21
This invention relates a therapeutic pharmaceutical composition comprising: a mixture including an opioid; polyethylene oxide in an amount of about 3 to about 40 wt % of the composition; a disintegrant; and a surfactant; wherein the disintegrant is present in an amount sufficient to cause the pharmaceutical composition to exhibit an immediate release profile.
Vijai KUMAR, David DIXON, Divya TEWARI, Dilip B. WADGAONKAR
Filed: 25 Nov 20
Utility
Methods and Compositions for Self-regulated Release of Active Pharmaceutical Ingredient
2 Dec 20
An abuse deterrent pharmaceutical composition including a pharmaceutically active ingredient; an acid soluble ingredient; and a buffering ingredient; wherein the acid soluble ingredient and the buffering ingredient retard release of the active pharmaceutical ingredient when the composition is ingested in excess of an intended dosage.
Albert W. Brzeczko, R. Gary Hollenbeck
Filed: 10 Jun 20
Utility
Methods and compositions for self-regulated release of active pharmaceutical ingredient
22 Jun 20
An abuse deterrent pharmaceutical composition including a pharmaceutically active ingredient; an acid soluble ingredient; and a buffering ingredient; wherein the acid soluble ingredient and the buffering ingredient retard release of the active pharmaceutical ingredient when the composition is ingested in excess of an intended dosage.
Albert W. Brzeczko, R. Gary Hollenbeck
Filed: 19 Jul 18
Utility
Methods and Compositions for Interfering with Extraction or Conversion of a Drug Susceptible to Abuse
17 Jun 20
Effective methods and compositions to deter abuse of pharmaceutical products (e.g., orally administered pharmaceutical products) including but not limited to immediate release, sustained or extended release and delayed release formulations for drugs subject to abuse.
Ronald L. LEECH, JR.
Filed: 26 Feb 20
Utility
Methods and compositions for interfering with extraction or conversion of a drug susceptible to abuse
6 Apr 20
Effective methods and compositions to deter abuse of pharmaceutical products (e.g., orally administered pharmaceutical products) including but not limited to immediate release, sustained or extended release and delayed release formulations for drugs subject to abuse.
Ronald L. Leech, Jr.
Filed: 17 May 18
Utility
Methods and compositions for self-regulated release of active pharmaceutical ingredient
14 Oct 19
An abuse deterrent pharmaceutical composition including a pharmaceutically active ingredient; an acid soluble ingredient; and a buffering ingredient; wherein the acid soluble ingredient and the buffering ingredient retard release of the active pharmaceutical ingredient when the composition is ingested in excess of an intended dosage.
Albert W. Brzeczko, R. Gary Hollenbeck
Filed: 7 May 17
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first